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Abstract
 
Proteasomes are the main proteases responsible for cytosolic protein degradation and the pro-
 
duction of major histocompatibility complex class I ligands. Incorporation of the interferon
 
 
 
–inducible subunits low molecular weight protein (LMP)-2, LMP-7, and multicatalytic en-
dopeptidase complex–like (MECL)-1 leads to the formation of immunoproteasomes which
have been associated with more efficient class I antigen processing. Although differences in
cleavage specificities of constitutive and immunoproteasomes have been observed frequently,
cleavage motifs have not been described previously.
We now report that cells expressing immunoproteasomes display a different peptide repertoire
changing the overall cytotoxic T cell–specificity as indicated by the observation that LMP-7
 
 
 
/
 
 
 
mice react against cells of LMP-7 wild-type mice. Moreover, using the 436 amino acid protein
enolase-1 as an unmodified model substrate in combination with a quantitative approach, we
analyzed a large collection of peptides generated by either set of proteasomes. Inspection of the
amino acids flanking proteasomal cleavage sites allowed the description of two different cleav-
age motifs. These motifs finally explain recent findings describing differential processing of
epitopes by constitutive and immunoproteasomes and are important to the understanding of
peripheral T cell tolerization/activation as well as for effective vaccine development.
Key words: constitutive proteasomes • immunoproteasomes • CTL epitope • peptide 
repertoire • tolerance
 
Introduction
 
CTLs are crucial for the defense against many invading or-
ganisms and certain tumors. Presentation of antigenic pep-
tides bound to MHC class I molecules is a prerequisite for
stimulation of a CTL response, and therefore plays a pivotal
role in providing CTLs with the capacity to respond to for-
eign antigens (1).
Peptides that meet the restrictive binding characteristics
of MHC class I molecules for presentation to CTLs are
generated after intracellular protein degradation by cytoso-
lic proteases. The central enzyme responsible for protein
degradation is the proteasome (2). Because of their inti-
mate involvement in antigen processing and presentation
(3), detailed knowledge on the cleavage preferences of
proteasomes will be crucial for understanding CTL
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epitope generation and thus, for the regulation of specific
immune responses.
The 20S proteasome represents the proteolytic core of
the larger 26S proteasome complex that encompasses either
one or two regulatory particles of at least 18 subunits (4).
The eukaryotic 20S particle is composed of 14 different but
related subunits organized in a barrel-shaped complex with
the stoichiometry 
 
 
 
7
 
 
 
7
 
 
 
7
 
 
 
7
 
. Three subunits of the two in-
ner 
 
 
 
-rings (
 
 
 
1, 
 
 
 
2, and 
 
 
 
5) participate directly in peptide
bond cleavage. They represent three distinct proteolytic
activities, designated as the chymotrypsin (ChT)
 
*
 
-like,
trypsin-like, and peptidyl-glutamylpeptide–hydrolyzing (PGPH)
activities (5, 6). As the NH
 
2
 
-terminal threonine residues re-
sponsible for peptide bond cleavage do not prefer certain
peptide bonds over others, the basis for the three distinct
proteolytic activities most likely resides in the characteris-
tics of the amino acids in the vicinity (pockets) of each ac-
tive NH
 
2
 
-terminal threonine (7).
Upon IFN-
 
 
 
 exposure of cells, the three active 
 
 
 
-sub-
units that are constitutively expressed in 20S proteasomes
can be replaced by three IFN-
 
 
 
–inducible homologues,
low molecular weight protein (LMP)-2 (
 
  
 
1i) (for Y
[
 
 
 
1]), multicatalytic endopeptidase complex–like (MECL)-1
(
 
 
 
2i) (for Z [
 
 
 
2]), and LMP-7 (
 
 
 
5i) (for X [
 
 
 
5]). Although
there is extensive sequence homology, these replacements
alter the nature of peptides that are generated by protea-
somes (8–12).
Proteasomes harboring these IFN-
 
 
 
–inducible subunits
are also called immunoproteasomes, as opposed to the con-
stitutively expressed “constitutive” proteasomes, because
immunoproteasomes were found to process a number of
viral epitopes with greater efficacy in vitro (13–16). Using
several artificial fluorogenic substrates in vitro, it was found
that immunoproteasomes display a better capacity to cleave
after hydrophobic and basic residues but are less well
equipped for cleavage after acidic amino acids (17). The
finding that proteasomes are responsible for the generation
of the correct COOH terminus of several CTL epitopes
(18, 19) and the notion that hydrophobic or positively
charged amino acids serve in most cases as COOH-termi-
nal anchor residues of MHC class I ligands led to the con-
cept that immunoproteasomes contribute to more efficient
MHC class I antigen processing. While this holds true for
most viral antigens, recent studies have shown that some
antigenic peptides are efficiently produced by constitutive
proteasomes but cannot be generated by immunoprotea-
somes (20). This demonstrates that immunoproteasomes
are not necessarily better suited for the processing of all
MHC class I ligands.
To better understand the reasons why certain MHC class
I ligands are generated with greater efficiency and others
 
with lower efficiency in cells expressing different sets of
proteasomes, we have performed an in-depth analysis of
peptide fragments generated after proteasomal cleavage.
We have employed a strictly quantitative method to an-
alyze a large collection of peptide fragments produced by
either set of proteasome. Our observations allowed the
identification of certain amino acids (or their characteris-
tics) in positions distant, or directly flanking the cleavage
sites selected by either set of proteasomes. The (quantified)
mapping of cleavage sites using a large protein substrate
provides the basis for a better understanding of proteaso-
mal cleavage specificity, allowing a refined proteasomal
cleavage prediction, which will be helpful for the identifi-
cation of new CTL epitopes, the design of new (recombi-
nant) vaccines, and for better insight into immunity
against infection.
 
Materials and Methods
 
Purification of 20S Proteasomes.
 
20S proteasomes were iso-
lated as described previously (9). Frozen pellets of LCL-721 cells
or LCL-721.174 cells were lysed in a buffer containing 0.1% Tri-
ton X-100 on ice and homogenized in a Dounce homogenizer.
The 40,000
 
  
 
g
 
 supernatant of the lysate was bound to DEAE
Sephacel. After elution, the protein fraction was concentrated and
loaded onto a 10–40% sucrose gradient. After centrifugation,
gradient fractions were tested for protease activity using the
fluorogenic substrates succinyl-leucyl-leucyl-valyl-tyrosyl-7-amino-
4-methylcoumarin (Suc-LLVY-AMC) and succinyl-tyrosyl-
valyl-alanyl-aspartyl-7-amino-4-methylcoumarin (Suc-YVAD-
AMC). Active fractions were pooled and further purified by
anion exchange chromatography on a MonoQ HR5/5 FPLC
column (Amersham Pharmacia Biotech). The purity of the pro-
teasome preparates, checked by SDS-PAGE, was 
 
 
 
95%. Quanti-
fication of native proteasome protein was determined by a varia-
tion of the Lowry Method (protein assay; Bio-Rad Laboratories)
and BSA as a standard.
 
Immunoblotting.
 
5 
 
 
 
g of purified proteasome polypeptides
were separated by 12% SDS-PAGE and transferred to polyvi-
nyldifluoride (DuPont) with a semidry transfer system. Human
LMP-7 was detected using a rabbit polyclonal antiserum in con-
junction with chemiluminescence (PW8200; Affiniti Research
Products, Ltd.).
 
In Vitro Degradation of Enolase-1.
 
150 
 
 
 
g of yeast enolase-1
were incubated in digestion buffer (20 mM Hepes/KOH, pH
7.6, 2 mM MgAc2, and 0.01% SDS) with proteasomes at a molar
ratio of 150:1. Digestions were stopped by freezing the samples at
 
 
 
80
 
 
 
C when 
 
 
 
50% of the substrate was digested (usually after
 
 
 
48 h).
 
Separation and Analysis of Cleavage Products.
 
For the separation
of degradation products, unfractionated enolase digests were sub-
jected to 
 
 
 
RP SC 2.1/10 columns (Amersham Pharmacia Bio-
tech) on a Microbore HPLC system (SMART; Amersham Phar-
macia Biotech). Buffer A contained 0.1% trifluoroacetic acid;
buffer B contained 0.081% trifluoroacetic acid and 80% acetoni-
trile. Gradients were 0% for 5 min, in 40 min to 40% in buffer B,
in 8 min to 75% in buffer B, and up to 85% in another 7 min at a
flow rate of 150 
 
 
 
l/min. Fractions were collected by peak frac-
tionation with a maximal volume of 500 
 
 
 
l/peak.
Peak fractions were dried and dissolved in 25 
 
 
 
l of 40% meth-
anol, 1% formic acid, and subsequently analyzed by matrix-asso-
 
*
 
Abbreviations used in this paper:
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ciated laser desorption ionization (MALDI) time of flight mass
spectrometry (MS) (G2025A; Hewlett Packard) and NH
 
2
 
-termi-
nal sequencing (Edman degradation) (pulsed liquid protein
sequencer procise 494A; Applied Biosystems). Alternatively,
peptides were analyzed on a hybrid quadruple orthogonal accel-
eration tandem mass spectrometer (Micromass). All these tech-
niques were applied as described previously (21). Pmol amounts
for each peptide detected in the HPLC fraction were determined
by Edman sequencing and used for the quantitative analysis of the
data.
 
Statistical Analysis - Frequencies of Amino Acids.
 
To detect sta-
tistically significant features in the amino acid distribution flank-
ing the cleavage sites, we compared percent values using a classic
chi-squared test for four tables (variance assumed due to count-
ing). This method was used to compare constitutive and immu-
noproteasomes fragments with each other and with enolase. For a
more thorough comparison of the absolute pmol amounts of
constitutive and immunoproteasomes, we accounted for the ex-
perimental variability and, according to the quasilikelihood ap-
proach of Wedderburn et al. (22), assumed a mean variance struc-
ture. We assumed the variance to be proportional to the mean
and fitted the proportionality constant 
 
 
 
 from all the data. Then,
the usual chi-squared test variable was scaled by 1/
 
 
 
, which led
asymptotically to a test variable that is chi-squared distributed
with one degree of freedom. The results of the latter was a more
thorough approach correlated to the approach neglecting experi-
mental variability and using percent values. Only chi-squared val-
ues
 
  
 
3.841 are considered to be significant.
 
Statistical Analysis - Comparison of Amino Acid Characteristics.
 
To compare the characteristics of amino acids, the observed fre-
quencies of amino acids at P6 to P6
 
  
 
around cleavage sites in both
proteasomes were compared with each other using the chi-
squared test. Hydrophobicity, bulkiness, and flexibility character-
istics (21) of both proteasomes and enolase were compared by
translating the percentage of amino acids found to the corre-
sponding hydrophobicity, bulkiness, and flexibility scales. This
resulted in spectra per cleavage site, and these were compared by
means of regression analysis.
 
Mice, CTL Assays, and Skin Grafting.
 
LMP-7
 
 
 
/
 
 
 
 mice were
generated as described previously (23) and maintained at the ani-
mal facilities of the Basel Institute for Immunology or the Insti-
tute for Cell Biology. C57BL/6 mice were obtained from
Charles River Laboratories. RMA and RMA-S cells were cul-
tured in RPMI 1640 containing 10% FCS, 2-Me, 
 
L
 
-glutamine,
and antibiotics. CTLs were generated by intraperitoneal immuni-
zation of mice with 10
 
7
 
 irradiated spleen cells (33Gy) in 300 
 
 
 
l
PBS. 10 d later spleens were removed and the splenocytes were
stimulated with irradiated spleen cells (33Gy). CTL lines were
generated by weekly restimulations with irradiated spleen cells as
described previously (24). CTL assays were performed as de-
scribed previously (24) using RMA, RMA-S, and concanavalin A
blasts of spleen cells as target cells. In addition, CTL lines were
tested on the LMP-7
 
 
 
/
 
 
 
 cell line BII-103 (unpublished data)
and BII-103 transfected with LMP-7 wild-type and LMP-7
T1A DNA.
The LMP-7 gene was cloned from a 129/Ola cDNA us-
ing oligonucleotides 5
 
 
 
 AGGATCCACCATGGCGTTACTG-
GATCTGTGCGG (with BamH1 site at the 5
 
 
 
 end) and 3
 
 
 
TGAATTCTCACAGAGCGGCCTCTC (with EcoR1 site at
the 3
 
 
 
 end). The DNA fragment was then digested with EcoR1
and BamH1 endonucleases and cloned into similarly digested
LZRSpBMN-linker-IRES-green fluorescent protein plasmid
(unpublished data). Mutagenesis of LMP-7 to replace T by A at
position 1 (in the processed subunit) was done using oligonucle-
otides 5
 
  
 
GGCCCACGGCGCAACCACACTCGCC and 3
 
 
 
GGCGAGTGTGGTTGCGCCGTGGGCC. LMP-7 wild-type
and LMP-7 T1A expressing retroviral vectors were transfected
into packaging cell lines and supernatants were used to infect the
LMP-7
 
 
 
/
 
 
 
 cell line BII-103. After appropriate selection, compa-
rable LMP-7 wild-type and LMP-7 T1A transcription was de-
tected by Northern blot analysis and comparable green fluores-
cent protein expression by FACS
 
® 
 
analysis (FACSCalibur™;
Becton Dickinson).
Skin grafts were performed on the back of the mice. Pieces of
skin (
 
 
 
7 mm of diameter) were obtained with a punch from the
back of shaved donors and grafted onto anesthesized recipients
where holes had also been made with a punch. Each animal had
two separated grafts, foreign and autologous, as an experimental
control. The skin was discreetly glued (histoacryl; B. Braun Sur-
gical AG) and bandaged. After a week, the bandage was removed
to allow the observation of the putative graft rejection.
 
Results
 
Isolation of Proteasomes.
 
Proteasomes were isolated from
EBV-transformed B cells. Constitutive proteasomes were
purified from cells (LCL-721.174) lacking LMP-2 and
LMP-7 due to a chromosomal deletion in the MHC locus
(20, 25). The lack of LMP-2 excludes the incorporation of
MECL-1 in 20S proteasomes. Therefore, this cell line con-
tains only proteasomes carrying active constitutive subunits
(26). The immunoproteasome preparation was isolated
from the parental line (LCL-721) that served for the gener-
ation of LCL-721.174.
As expected, only proteasomes isolated from LCL-721
cells expressed immuno subunits, as exemplified by the
presence of LMP-7 (Fig. 1, a and b). Moreover, these pro-
teasomes showed a reduced ability to release fluorogenic
groups linked to acidic amino acids compared with protea-
somes isolated from LCL-721.174 cells (data not shown).
Together, these data indicate that proteasomes purified
from LCL-721, although containing some constitutive pro-
Figure 1. Immunosubunit in-
corporation into 20S protea-
somes purified from LCL-721
cells (left) but not into 20S protea-
somes derived from LCL-721.174
cells (right). 20S proteasomes
were isolated from LCL-721 and
LCL-721.174 cells as described
in Materials and Methods. Pro-
teasome subunits were sepa-
rated by SDS-PAGE (a) and
probed with an LMP-7–specific
antiserum (b). LMP-7 was only
detected in 721 proteasomes. i
or c indicate subunits exclusively present or overexpressed in i20S or
c20S proteasomes, respectively. 
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teasomes, behave like immunoproteasomes with very little
PGPH activity, whereas LCL-721.174–derived protea-
somes can be classified as constitutive proteasomes with
high PGPH activity.
 
Digestion of Enolase.
 
Although the ability of constitu-
tive and immunoproteasomes to cleave a set of standard
fluorogenic substrates or some CTL epitope containing
peptides has been well documented, little is known about
the selection of cleavage sites during the degradation of
proteins, especially on a quantitative basis. To obtain fur-
ther insight into these cleavage preferences, we used the
complete protein enolase-1 from yeast as substrate which
can be digested by proteasomes in vitro without prior
modifications. Enolase is a 436 amino acid–long protein in
which the frequency of amino acids resembles the average
amino acid frequency in proteins (27). Digestion of enolase
was performed by incubation of enolase with constitutive
or immunoproteasomes at a molar ratio of 150:1. The re-
action was stopped when 
 
 
 
50% of the substrate was de-
graded to ensure comparable substrate turnover. This de-
gree of degradation was obtained after 48 h, indicating
similar rates of digestion for both constitutive and immu-
noproteasomes. Subsequently, enolase fragments were sep-
arated by reverse-phase HPLC. Comparison of two in-
dependent digests obtained after incubation with two
independent constitutive proteasome batches revealed that
highly comparable degradation profiles were obtained. The
generation of similar degradation products was confirmed
by MALDI-MS analyses of several fractions that eluted at
the same time (data not shown).
After having established the reproducibility of the diges-
tion profiles, the peptide fragments in all fractions were an-
alyzed by MALDI-MS, in combination with Edman deg-
radation, and compiled in a digestion map (Fig. 2).
Approximately 50% of cleavages generated by constitutive
proteasomes were not produced by immunoproteasomes.
Indeed, when the identity of fragments produced by either
set of proteasome was compared on a qualitative basis only
 
 
 
25% of peptides produced by immunoproteasomes were
also found in constitutive proteasome digests. Therefore,
the pool of peptides generated by cells expressing immuno-
proteasomes is very different from the peptide pool gener-
ated by cells harboring constitutive proteasomes only.
 
Quantification of Digestion Profiles.
 
For careful examina-
tion of proteasomal cleavage preferences, it is important to
know the quantity of each fragment to calculate how often
particular cleavage sites are selected. In contrast to MS data,
data acquired by Edman sequencing are quantitative and
can thus be used to determine the amount of peptide liber-
ated. The combination of MS analysis and the quantified
Edman sequencing data identified the absolute amount of
each peptide detected in HPLC fractions. In the constitu-
tive proteasome digests, a total of 136 fragments was de-
tected, representing 6,135 pmol of peptide (Table I). By
adding the pmol of all fragments starting or ending at a par-
ticular cleavage site (and then choosing the higher one of
the two sums), pmol amounts of peptide generated from a
given cleavage site, and thus the frequency of cleavage site
utilization, was determined. The most frequently used
cleavage sites were found at amino acid positions 278 and
404, resulting in the liberation of 265 pmol peptide each
(Table I, top). As usage of many other cleavage sites re-
sulted in only 5 pmol of peptide, these data indicate that
the relative usage of cleavage sites within one protein can
differ substantially.
Similar data were obtained when the immunoprotea-
some digest was analyzed (123 peptides representing 6,370
pmol of peptide; Table II). The most prominent cleavage
site was found at amino acid position 419, resulting in the
generation of 250 pmol peptide (Table II, top). As for con-
stitutive proteasomes, many other cleavage sites were used
less often, indicating that both proteasome species prefer
certain peptide bonds over others as cleavage sites. The al-
most identical amounts of peptides generated by both pro-
Figure 2. Digestion map generated from degradation of enolase by
constitutive proteasomes (a) and immunoproteasomes (b). Vertical lines,
cleavage sites determined by Edman degradation and/or MS; black bars,
degradation products identified by Edman degradation in combination
with MS; white bars, degradation products identified by Edman degrada-
tion only (COOH terminus of peptide not identified). 
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teasomes (6,135 pmol versus 6,370 pmol) demonstrate a
comparable substrate turnover, allowing a direct compari-
son of pmol amounts of amino acids at different positions
around cleavage sites as well as a comparative statistical
analysis of both digests.
Comparison on a qualitative and quantitative basis of the
fragment length distributions revealed that both protea-
some species generated peptides with an average length of
7–9 amino acids (c20S, 7.4 aa; i20S, 8.6 aa) with 30% of
the peptides produced by constitutive proteasomes being
 
identical to those generated by immunoproteasomes (Fig.
2). Together, these findings strongly indicate that in cells
harboring constitutive or immunoproteasomes, respec-
tively, the pool of peptides generated from proteasomal
protein turnover will differ substantially.
 
Analysis of Cleavage Site Usage.
 
As outlined above,
some cleavage sites are used often, whereas others are used
less frequently or not at all by one or both proteasome spe-
cies. Until now, most studies addressing the specificity of
proteasomal peptide/protein degradation did not take the
 
Table I.
 
Absolute Amounts of Amino Acids Found in Positions P6 to P1 and P1
 
 
 
 to P6
 
 
 
 of Peptides Generated by Constitutive Proteasomes
 
Pos Pmol P6-P1 P1
 
 
 
-P6
 
 
 
278 265
 
LTGPQL ADLYHS
 
404 265
 
APARSE RLAKLN
 
383 185
 
TEDTFI ADLVVG
 
31 175
 
EKGVFR SIVPSG
142 165 SKSKTS PYVLPV
183 165 TFAEAL RIGSEV
230 165 LDLIVD AIKAAG
330 155 TNPKRI ATAIEK
146 150 TSPYVL PVPFLN
79 145 PAFVKA NIDVKD
P6 P5 P4 P3 P2 P1 P1  P2  P3  P4  P5  P6 
A 865 595 1,020 485 620 825 1,545 330 710 590 930 365
C 0 0 00 1 3 0 0000000
D 580 460 255 215 185 805 300 1,185 315 235 170 400
E 530 465 385 455 250 605 300 275 460 150 465 440
F 50 275 430 165 430 145 190 250 165 575 220 50
G 300 575 750 230 545 175 185 415 760 185 320 780
H 175 125 10 150 280 65 165 110 65 35 385 90
I 505 125 385 335 180 510 60 845 220 450 405 170
K 220 580 240 945 455 80 365 115 370 675 600 655
L 540 550 535 525 230 1,185 345 900 1,120 435 670 565
M 10 0 95 10 15 35 70 40 75 65 10 60
N 120 285 235 140 240 95 390 215 195 160 270 730
P 365 475 550 365 95 40 480 20 255 240 330 315
Q 45 260 25 20 340 60 75 60 155 305 35 75
R 125 45 45 425 290 275 595 95 155 145 80 60
S 575 365 380 90 535 395 500 215 170 530 490 555
T 735 460 140 365 365 140 150 430 140 360 250 105
V 270 380 365 920 840 450 275 410 695 705 355 695
W 40 15 35 30 20 30 0 50 0 0 50 10
Y 85 100 255 265 90 220 145 175 110 295 100 15
sum (pmol) 6,135 6,135 6,135 6,135 6,135 6,135 6,135 6,135 6,135 6,135 6,135 6,135
(Top) 10 most abundant cleavage sites from P6-P1 and P1 -P6 , the position of the cleavage site (pos), and the calculated amount of enolase that has
been cleaved at this position (pmol; see also Materials and Methods). (Bottom) Based upon quantified data (as exemplified on top), the absolute
amounts of amino acids (in pmol) around all identified cleavage sites are shown.6 Cleavage Motifs of Constitutive and Immunoproteasomes
frequency of cleavages into account. To study more accu-
rately the influence of all 20 amino acids flanking proteaso-
mal cleavage sites, we determined the frequency of amino
acids around cleavage sites (P6 to P1 NH2-terminal of
cleavage site; P1  to P6  COOH-terminal of cleavage site)
using the quantified data set described above (Tables I and
II, and Fig. 3). No statistically significant differences in
cleavage site selection were observed between two inde-
pendent digests performed by two independent immuno-
proteasome batches, indicating that the fragment pattern
obtained after proteasomal degradation was highly repro-
ducible (data not shown).
Examination of cleavages performed by immunoprotea-
somes revealed several deviations from randomness at the
amino acid level (i.e., the background in enolase) as deter-
mined by chi-squared analyses (data not shown). L as P1
residue has the highest preference (chi-squared   21) and
reflects a pronounced ChT-like activity within immuno-
proteasomes. Weaker preferences for D at P2  (chi-squared  
6.2) are also evident. On the other side, several residues are
Table II. Absolute Amounts of Amino Acids Found in Positions P6 to P1 and P1  to P6  of Peptides Generated by Immunoproteasomes
Pos Pmol P6-P1 P1 -P6 
419 250 RIEEEL GDNAVF
390 200 DLVVGL RTGQIK
183 155 TFAEAL RIGSEV
313 155 HFFKTA GIQIVA
133 150 PLYKHL ADLSKS
142 150 SKSKTS PYVLPV
253 150 ASSEFF KDGKYD
285 150 DLYHSL MKRYPI
289 150 SLMKRY PIVSIE
383 150 TEDTFI ADLVVG
P6 P5 P4 P3 P2 P1 P1  P2  P3  P4  P5  P6 
A 680 615 940 420 590 745 1,440 665 560 775 480 810
C 0 0 0000000000
D 725 360 190 225 160 150 335 1,210 255 325 220 375
E 300 370 515 870 580 155 255 320 410 270 400 515
F 0 495 280 105 665 550 50 100 120 260 190 250
G 500 550 485 180 360 170 880 475 970 265 465 675
H 300 35 80 285 205 130 140 40 50 40 340 285
I 440 345 290 470 145 585 20 800 295 420 730 395
K 90 475 400 1,065 620 175 450 275 290 405 590 830
L 560 975 450 235 160 2,305 65 370 1,025 410 105 510
M 20 0 215 10 80 50 295 0 0 100 0 50
N 245 285 290 165 205 95 520 290 560 575 190 290
P 325 370 255 380 35 0 375 175 305 180 440 80
Q 10 260 210 105 170 10 175 75 225 250 100 20
R 365 100 65 215 395 200 480 0 190 290 320 100
S 545 250 610 225 735 185 345 320 265 695 380 520
T 890 200 85 235 570 195 310 560 275 195 275 55
V 255 485 585 940 695 320 85 535 495 555 925 610
W 25 60 0 25 0 70 0 0 0 75 0 0
Y 95 140 425 215 0 280 150 160 80 285 220 0
sum (pmol) 6370 6,370 6,370 6,370 6,370 6,370 6,370 6,370 6,370 6,370 6,370 6,370
(Top) 10 most abundant cleavage sites from P6-P1 and P1 -P6 , the position of the cleavage site (pos), and the calculated amount of enolase that has
been cleaved at this position (pmol; see also Materials and Methods). (Bottom) Based upon quantified data (as exemplified on top), the absolute
amounts of amino acids (in pmol) around all identified cleavage sites are shown.7 Toes et al.
found less frequently than expected with the hydrophobic
amino acids I, L, and V (chi-squared    4.3) at P1  being
the most prominent. This finding reflects the preference of
proteasomes to cleave behind rather than in front of L resi-
dues, for example. Apart from these amino acids at the P1 
position, L at P2 was found less abundantly than expected.
When amino acids are grouped according to their charac-
teristics, it was found that there was a positive correlation
between cleavage and the presence of hydrophobic, and
bulky amino acids in P1 (P   0.0002).
An analogous examination for the cleavages selected by
constitutive proteasomes revealed that the frequency of S as
P3 and the positively charged amino acid K as P1 and P2 
residue is reduced (all chi-squared   3.9), indicating that
these amino acids are disfavored by constitutive protea-
somes at these positions. Constitutive proteasomes show a
weak enrichment of P at P4 (chi-squared   3.8) and, like
immunoproteasomes, prefer A at P1  and L as P1 residue
(albeit to a lesser extent; chi-squared   4.2). Similarly, an
enrichment for D at P2  was noted (chi-squared   8.5), in-
dicating that both proteasome species have a preference for
negatively charged amino acids at the P2  position. When
comparing characteristics of amino acids at these positions,
a preference for hydrophobic, bulky amino acids in P1 and
P2  (P   0.0002) was observed. There is a negative corre-
lation between cleavage site selection and the presence of
hydrophobic, bulky amino acids in P1  (P   0.0002).
Effect of Immunosubunit Incorporation on Cleavage Site Selec-
tion. The data described above reveal that both protea-
some species exhibit a different, but partially overlapping (L
in P1, A in P1 , and D in P2 ) cleavage preference. How-
ever, they do not address directly the influence of immu-
nosubunit incorporation on cleavage site selection. There-
fore, we compared relative amino acid frequencies around
cleavage sites used by immunoproteasomes to those used
by constitutive proteasomes. As a control, we evaluated
cleavage site selection of two independent immunoprotea-
some batches yielding no statistically significant differences
(data not shown). For comparison between constitutive
and immunoproteasomes for positions P6-P6 , significant
differences were found at position P1 (P   0.004) and, to a
lesser extent, also at P1 . When testing for amino acid char-
acteristics, we found that immunoproteasomes prefer
bulky, hydrophobic amino acids at P1 (P   0.003) but dis-
like flexible amino acids at this position (P   0.001). At
position P1  we found that hydrophobic, bulky amino ac-
ids were favored more by constitutive proteasomes (P  
0.04). Thus, comparison of peptide bonds used as cleavage
sites by immunoproteasomes to the ones used by constitu-
tive proteasomes revealed a pronounced ChT-like activity
of immunoproteasomes, as is reflected by a strong enrich-
ment of hydrophobic amino acids in P1. When comparing
the two proteasome species for individual amino acid us-
age, a strong enrichment of L (chi-squared   7.1 and, to a
lesser extent F, chi-squared   3.8) was detected at P1 in
peptides generated by immunoproteasomes. The strong
enrichment of L became most prominent when we ana-
lyzed in detail those cleavages exclusively generated by im-
munoproteasomes, as 43% of these cleavages were per-
formed after L (data not shown). Acidic amino acids D and
E in P1 exert a negative influence on cleavage site selection
by immunoproteasomes (chi-squared   4.5 and 8.1, re-
spectively). G in P1  is enriched in peptides generated by
immunoproteasomes (chi-squared    7.8), pointing to a
preference of immunoproteasomes for this small amino
acid in P1 . Analysis of amino acid frequencies at positions
P2 to P6 and P2  to P6  showed that L at P2  is disfavored
by immunoproteasomes (chi-squared   4.3).
Effect of Immunosubunit Incorporation on CTL Induction.
The observed major differences in the peptide repertoire
produced by constitutive and immunoproteasomes could
have important biological implications that go beyond dif-
ferential proteasomal processing of certain CTL epitopes
(8, 13–16, 20). To study the biological consequences of
immunosubunit incorporation in vivo, we tested the im-
mune response of LMP-7 /  mice lacking functional im-
munoproteasomes (28) against wild-type cells. If immuno-
proteasome incorporation affects the nature of the CTL
epitopes presented, it is expected that wild-type cells ex-
pressing both constitutive and immunoproteasomes will in-
duce a CTL response in mice expressing constitutive pro-
teasomes only. The opposite direction should not lead to a
CTL response, as no unique (“immuno”) peptides are pre-
sented in this setting. Indeed, skin grafting experiments
showed that wild-type mice were not able to reject skin
from LMP-7 /  animals (23), which are not able to express
functional immunoproteasomes because in the absence of
the LMP-7 subunit, LMP-2 and MECL-1 subunits are
only incorporated in 20S proteasomes as inactive precursors
(28). However, LMP-7 /  mice rejected skin transplants
Figure 3. Relative frequencies of amino acids in position P1 (a) P1 
(b). The absolute amount of amino acids found in a defined positions (P6
to P6 ) around cleavage sites used by constitutive proteasomes and im-
muoproteasomes was divided by the total amount of peptides detected in
the digests resulting in the relative frequency of amino acid usage in that
position. Big white bars, relative frequency of amino acids found in eno-
lase; black bars, relative frequency of amino acids at P1 or P1  positions in
peptide fragments generated by constitutive proteasomes; grey bars, rela-
tive frequency of amino acids at P1 or P1  in peptide fragments generated
by immunoproteasomes.8 Cleavage Motifs of Constitutive and Immunoproteasomes
from wild-type mice with even greater efficiency than ob-
served for the rejection of male skin by female recipients
(Fig. 4 a). The fact that the latter rejection is mediated over
several antigenic differences (29) supports the argument
that LMP-7 /  mice react against multiple antigenic differ-
ences present on LMP-7 wild-type skin.
The identical scenario was observed for the induction of
CTL responses. Vaccination of wild-type mice with cells
derived from LMP-7 /  mice did not generate a CTL
response. In contrast, LMP-7 /  mice readily mounted
a strong, transporter-associated with antigen processing
(TAP)-dependent CTL response upon vaccination with
wild-type cells harboring both proteasome species (Fig. 4
b). Cell lines expressing an inactive LMP-7 T1A subunit
were recognized with a 30-fold lower efficiency compared
to cells expressing the LMP-7 wild-type subunit despite
equal expression levels of both gene products and H-2 class
I molecules (data not shown). This finding argues against
the possibility that CTL responses against a peptide from
the LMP-7 protein itself have been induced. The fact that
LMP-7 T1A transfectants are still recognized to some ex-
tent by CTLs from LMP-7 /  mice can be explained by
the observation that some CTL epitopes, not produced in
LMP-7 /  mice, can be generated by proteasomes carrying
both catalytically active or inactive LMP-7 subunits, as re-
ported for immunoproteasome-mediated CTL epitope
generation from viral antigens (14, 30). The recognition of
these epitopes on LMP-7 T1A transfectants would result in
a CTL activity above the one induced by LMP-7 /  cells
but below the one induced by LMP-7 wild-type cells.
Together, our findings indicate that the incorporation of
immunosubunits strongly influences the repertoire of pep-
tides presented to CTLs and thereby the overall specificity
of the CTL response.
Discussion
The proteasome is the key enzyme responsible for cyto-
solic protein degradation and generation of peptides that
are presented by MHC class I molecules by liberation of
their proper COOH termini. However, proteasomes also
can prevent MHC class I presentation by destruction of
potential MHC ligands or their inability to select the
proper COOH-terminal cleavage site. Cleavage site selec-
tion might change substantially after incorporation of IFN-
 –inducible subunits, as indicated by experiments using
small fluorogenic substrates or short synthetic peptides.
Therefore, detailed knowledge on the specificity of protein
degradation by either constitutive or immunoproteasomes
is crucial to the understanding and prediction of CTL
epitope generation.
To analyze alterations of cleavage preference upon im-
munosubunit incorporation we used an entire protein as a
substrate without modification of amino acids or bias to
known CTL epitopes. The quantitative identification of
 120 peptide fragments generated by either constitutive or
immunoproteasomes allowed a detailed analysis of the
cleavage specificities. Our data reveal that especially the
amino acids in P3 to P3  have a strong influence on cleav-
age site selection as the observed frequencies of amino acids
in these locations showed the largest discrepancy to their
background frequencies in enolase. Nonetheless, amino ac-
ids further away most likely influence cleavage site selection
as well, as was reported earlier for the effect of P at P4 on
peptide bond cleavage by yeast and constitutive human pro-
teasomes (21, 31–33). The average length of fragments pro-
duced by either set of proteasome is the same, showing that
spacing at which specific cleavage sites of the substrate are
recognized is not changed by immunosubunit incorpora-
tion.
By comparing flanking residues around cleavage sites,
we found that both proteasomes display a partially overlap-
ping but different cleavage specificity (Figs. 3 and 5). They
Figure 4. (a) Skin of the indicated donors were grafted on the back of
the indicated recipient mice according to the protocol described in Materi-
als and Methods. Graft rejection was controlled daily. Each dot represents a
single recipient. This graph shows a representative result of four indepen-
dent experiments. (b) LMP-7 /  mice and wild-type littermates (129/Ola
background) were immunized with wild-type or LMP-7 /  splenocytes.
CTL activity was tested after in vitro stimulation on LMP-7 /  and wild-
type concanavalin A blasts, RMA, and RMA-S cells as described in Mate-
rials and Methods. This graph shows a representative result of three inde-
pendent experiments.9 Toes et al.
both prefer L as P1 residue and K in P3; A in P1  and D in
P2  were also favored. Nonetheless, immunoproteasomes
have a much stronger preference for L at P1, as well as
other hydrophobic amino acids in this position. These
findings point to a pronounced ChT-like activity after im-
munosubunit incorporation. In contrast, the acidic amino
acids D and E were clearly disfavored by immunoprotea-
somes, whereas these amino acids were enriched at P1 in
peptides generated by constitutive proteasomes. Some of
the different characteristics regarding amino acid prefer-
ences at the P1 position were also observed previously in a
small number of fragments generated from covalently
modified lysozyme using proteasomes from bovine spleen
and pituitaries (12).
Our observations most likely reflect the characteristics of
amino acids at the inner surface of the proteasome. Analysis
of the contribution of individual active   subunits to cleav-
age site selection in yeast 20S proteasomes (5, 21), revealed
that the active site of  1 prefers to cleave after acidic resi-
dues,  2 after basic residues, and  5 after hydrophobic res-
idues. Structural analysis of proteasomes has shown that the
pockets around the active site threonine of  5 and  2 do
not change after immunosubunit incorporation (7). There-
fore, it can be expected that the cleavage site–flanking
amino acids that are preferred by both proteasomes (K in
P3, L in P1, A in P1 , and D in P2 ) correlate with the
characteristics of amino acids in the vicinity of the S-1
pockets of  5/  5i and/or  2/ 2i.
The enhanced preference for hydrophobic amino acids
at P1 of immunoproteasomes does not probably result from
exchange of  5, which mediates the ChT-like activity, for
 5i (LMP-7), as replacement of  5 for  5i does not alter
the pocket surrounding the active site threonine. More-
over, functional data indicate that  5i influences the struc-
tural features of 20S proteasomes, thereby enhancing the
activity of  1i (LMP-2; references 14 and 30). The stron-
ger preference of immunoproteasomes for hydrophobic
amino acids at P1, however, correlates with the characteris-
tics at the inner surface of the proteasome when  1 (Y) is
replaced for  1i. Replacement of  1 for  1i is predicted to
cause the formation of a more apolar pocket around the ac-
tive site threonine. This most likely results in the accom-
modation of hydrophobic amino acids at P1, leading to an
enrichment of peptides with hydrophobic COOH termini
and a reduction of fragments with charged COOH termini
(7). Thus, it is conceivable that the exchange of  1 for  1i
causes a reduction of peptides with charged COOH ter-
mini (amino acids like D and E) and enhanced liberation of
peptides with hydrophobic COOH termini.
Structural analyses of proteasomes also predict that the
active S-1 pocket of  5i is more constricted than the
pocket of  5 (7). As most hydrophobic amino acids are
rather bulky, it is possible that small and flexible amino ac-
ids, like G, in close vicinity to hydrophobic amino acids,
support accommodation of these amino acids in the S1
pocket of  5i most efficiently. Therefore, we anticipate
that the strong enrichment of G and the decrease of hydro-
phobic amino acids in P1  of cleavage sites selected by im-
munoproteasomes are a direct consequence of these altered
characteristics of the  5 immunosubunit.
The observation that the P1 preference of immunopro-
teasomes closely resembles the preferences of the F pocket
of most MHC class I molecules is thought to explain why
immunoproteasomes are associated with more efficient
processing of MHC class I ligands, either by generating
CTL epitopes directly or by producing more CTL epitope
precursors that are converted into CTL epitopes by the ac-
tion of aminopeptidases. As some CTL epitopes are prefer-
entially generated by immunoproteasomes (34), it is postu-
lated that immunoproteasome expression is generally
associated with more efficient CTL epitope generation.
However, the correlation between epitope production and
expression of immunoproteasomes is more subtle. Some
MHC class I alleles harbor F pockets that allow the binding
of amino acids with charged polar side chains (e.g., K and
R). These MHC alleles are unlikely to profit from immu-
noproteasome expression, as the trypsin-like activity is not
enhanced by immunosubunit incorporation.
In view of our results, increased CTL epitope generation
can now be explained and also predicted by several differ-
ent mechanisms. Examples of quantified fragment genera-
tion from synthetic peptides by constitutive and immuno-
proteasomes are listed in Table III. They include (a)
Figure 5. Summary of cleavage motifs. Amino acid preferences at
positions flanking the cleavages performed by constitutive (c20S) or im-
munoproteasomes (i20S) are indicated by bars pointing up (enriched)
or down (decreased). Amino acid frequencies around cleavage sites
were compared with amino acid frequencies in enolase. i20S versus
c20S indicates a comparison of amino acid preferences between both
types of proteasomes. Amino acid frequencies around cleavage sites
were compared with each other. Bars pointing up indicate a i20S pref-
erence, bars pointing down indicate a c20S preference. Amino acids are
shown in one-letter code by capital letters, and amino acid characteris-
tics are indicated by small letters. A decrease in preferences for hydro-
phobic and bulky amino acids also indicates an increase in preferences
for polar and small amino acids, respectively and vice versa. h, hydro-
phobic; f, flexible; b, bulky.10 Cleavage Motifs of Constitutive and Immunoproteasomes
enhanced liberation of the proper NH2 and/or COOH ter-
minus by i20S proteasomes resulting from the combination
hydrophobic amino acid, small (and polar) amino acid at P1
and P1 , respectively (hepatitis B core antigen 141–151,
lymphocytic choriomeningitis virus [LCMV] pp89, and ad-
eno virus E1B), (b) enhanced generation of TAP-compati-
ble CTL epitope precursors due to increased i20S protea-
some activity for the combination hydrophobic amino
acid, small (and polar) amino acid at P1 and P1 , respec-
tively (LCMV pp89, LCMV nucleoprotein [NP]), or (c)
reduced PGPH activity of i20S proteasomes not destroying
the CTL epitope (influenza A NP). However the combi-
nation hydrophobic amino acid, small (and polar) amino
acid at P1 and P1  within a CTL epitope can also favor its
destruction by i20S proteasomes as shown for a CTL
epitope derived from the ubiquitous self-protein RU1.
The finding that the peptide pool generated by immu-
noproteasomes differs from the one produced by constitu-
tive proteasomes leads to important biological conse-
quences as also shown by the effect of immunosubunit
incorporation on skin graft rejection and CTL induction
(Fig. 4). Recently, it was found that dendritic cells and
other professional APCs express immunoproteasomes (20).
In contrast, most cells outside the lymphoid system harbor
mainly constitutive proteasomes, unless they are exposed to
inflammatory stimuli. These findings indicate that the pep-
tide pool available to MHC molecules, and thus for pre-
sentation to the immune system, differs substantially
between professional APCs and nonlymphoid cells. Profes-
sional APCs are not only involved in T cell priming, they
also play a pivotal role in central and peripheral T cell tol-
erization (35–37). They can tolerize against endogenously
expressed antigens, but also against antigens acquired from
exogenous sources (cross-tolerization; reference 38). Al-
though these antigens are derived from nonlymphoid cells
that only express constitutive proteasomes, tolerance will
be induced against self-peptides that are generated by cells
expressing immunoproteasomes. During viral infection, vi-
rus-infected cells but also neighboring cells will be exposed
to inflammatory cytokines, leading to immunoproteasome
expression. Because tolerance has been adjusted to the pep-
tide pool expressed by cells harboring immunoprotea-
somes, self-reactive immune attack is thus reduced to a
minimum.
These considerations might also be relevant for induc-
tion of CTL immunity against ubiquitously expressed self-
proteins. If tolerance to self-proteins was restricted to pep-
tides generated by immunoproteasomes, nonlymphoid cells
expressing constitutive proteasomes would display peptides
for which no CTL tolerance has been induced. In this re-
spect, it is noteworthy that all CTL epitopes derived from
ubiquitous self-proteins (like RU1, Mage-1, gp100, and
Melan-A; reference 20) identified thus far are generated less
efficiently by immunoproteasomes, whereas presentation of
viral epitopes is, in general, enhanced after immunoprotea-
some expression (8, 13–16).
The combination of MHC class I ligand motifs and con-
stitutive/immunoproteasomal cleavage motifs for T cell
epitope prediction will enhance progress in precise manip-
ulation of specific immune responses. For example, it
should now be possible to identify new CTL epitopes pref-
erentially generated by constitutive proteasomes (like the
RUI epitope). Such peptides are attractive candidates to be
used as cancer vaccines, especially if they are derived from
antigens that are, for example, overexpressed in tumors.
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NAPIL STLPETTVVRRRGRSPR HbcAg 141–151 HLA-Aw68   14
 
RGVQI ASNENMD AMDSRTLELR Influenza A NP H2-Db   35
  
LMY DM YPHFMPTNL GPSEKR LCMV pp89 H2-Ld   8
  
KIM RTE RPQASGVYM GNLTAQ LCMV NP H2-Ld   16
 
YKISKL VNIRNCCYI SGNGAE Adeno E1B H2-Kb   13
 
TGSTAVPYGSF KHVDTRLQ
RUI HLA-B51   20
aCleavages performed at comparable amounts by c20S and i20S proteasomes are not indicated. HBcAg, hepatitis B core antigen;  , i20S preference;
 , c20S preference.11 Toes et al.
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